Calero, M. V., Patnaik, A., Maki, R., O’Neil, B., Abbruzzese, J., Dagogo-Jack, I., … Ahnert, J. (2022). Design of a Phase 1 Study of AMG 193, an MTA-Cooperative PRMT5 Inhibitor, in Patients with Advanced MTAP-Null Solid Tumors. In JOURNAL OF THORACIC ONCOLOGY (Vol. 17, pp. S457–S457).

Calero, M Villalona, A. Patnaik, R. Maki, B. O’Neil, J. Abbruzzese, I. Dagogo-Jack, S. Devarakonda, et al. “Design of a Phase 1 Study of AMG 193, an MTA-Cooperative PRMT5 Inhibitor, in Patients with Advanced MTAP-Null Solid Tumors.” In JOURNAL OF THORACIC ONCOLOGY, 17:S457–S457, 2022.

Calero MV, Patnaik A, Maki R, O’Neil B, Abbruzzese J, Dagogo-Jack I, et al. Design of a Phase 1 Study of AMG 193, an MTA-Cooperative PRMT5 Inhibitor, in Patients with Advanced MTAP-Null Solid Tumors. In: JOURNAL OF THORACIC ONCOLOGY. 2022. p. S457–S457.

Calero, M. Villalona, et al. “Design of a Phase 1 Study of AMG 193, an MTA-Cooperative PRMT5 Inhibitor, in Patients with Advanced MTAP-Null Solid Tumors.” JOURNAL OF THORACIC ONCOLOGY, vol. 17, no. 9, 2022, pp. S457–S457.

Calero MV, Patnaik A, Maki R, O’Neil B, Abbruzzese J, Dagogo-Jack I, Devarakonda S, Wahlroos S, Lin CC, Fujiwara Y, Terbuch A, Postel-Vinay S, Goebeler ME, Addeo A, Prenen H, Arkenau T, Sacher A, Liu C, Kormany W, Ahnert J. Design of a Phase 1 Study of AMG 193, an MTA-Cooperative PRMT5 Inhibitor, in Patients with Advanced MTAP-Null Solid Tumors. JOURNAL OF THORACIC ONCOLOGY. 2022. p. S457–S457.